Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase(®))

Background: The introduction of new drugs that increase the usage of repurposed medicines for managing drug-resistant tuberculosis (DR-TB) comes with challenges of understanding, properly managing, and predicting adverse drug reactions (ADRs). In addition to the health consequences of ADRs for the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Duga, Alemayehu Lelisa, Salvo, Francesco, Kay, Alexander, Figueras, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215388/
https://www.ncbi.nlm.nih.gov/pubmed/37237714
http://dx.doi.org/10.3390/antibiotics12050811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215388/
https://www.ncbi.nlm.nih.gov/pubmed/37237714
http://dx.doi.org/10.3390/antibiotics12050811

Ejemplares similares